Skip to content
zameds

Pramipexole (Oxpola)

Pramipexole

Gulf Drug Company (Pty) Ltd

S4

Registration

Applicant
Gulf Drug Company (Pty) Ltd
Registrations
3
Schedule source
Consolidated Schedules 06 July 2026

Variants

ProductStrength and formRegistrationStatusScheduleLeaflets
Oxpola 0,25 MG

EACH TABLET CONTAINS PRAMIPEXOLE DIHYDROCHLORIDE 0,25 mg

0,25 mg43013343/5.4.1/0133RegisteredS4None
Oxpola 0,125 MG

EACH TABLET CONTAINS PRAMIPEXOLE DIHYDROCHLORIDE 0,125 mg

0,125 mg43013443/5.4.1/0134RegisteredS4None
Oxpola 1,0 MG

EACH TABLET CONTAINS PRAMIPEXOLE DIHYDROCHLORIDE 1,0 mg

1,0 mg43013543/5.4.1/0135RegisteredS4None

Regulatory status

Where S4 sits on the scale

Prescription-only medicine.

Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.

Schedule S4, matched to the Consolidated Schedules by ingredient, confidence medium.

Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.

Consolidated Schedules listings for Pramipexole dihydrochloride

  • S4: Pramipexole

    Consolidated Schedules 06 July 2026, line 7626

Pharmacological class: Anti-Parkinsonism preparations. (class 5.4.1)

This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.

C10H17N3S211.33 g/mol

(6S)-6-N-Propyl-4,5,6,7-tetrahydro-1,3-benzothiazole-2,6-diamine

Drag to rotate. Structure from PubChem CID 119570.

SAHPRA documents

SAHPRA has not published a professional information or patient information leaflet for this product.

Background

Loading...
Loading Wikipedia summary

Research articles

Loading...
Loading PubMed articles